Recent developments in immunotherapy for gastrointestinal tract cancers-Reference-Cited by-同舟云学术

Recent developments in immunotherapy for gastrointestinal tract cancers

Published:2024-08-09 Issue:1 Volume:17 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Chong Xiaoyi,Madeti Yelizhati,Cai Jieyuan,Li Wenfei,Cong Lin,Lu Jialin,Mo Liyang,Liu Huizhen,He Siyi,Yu Chao,Zhou Zhiruo,Wang Boya,Cao Yanshuo,Wang Zhenghang,Shen Lin,Wang Yakun,Zhang Xiaotian

Funder

Capital's Funds for Health Improvement and Research

Beijing Natural Science Foundation

National Natural Science Foundation of China

Peking University Medicine Fund for world's leading discipline or discipline cluster development

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s13045-024-01578-x.pdf

Reference504 articles.

1. Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. https://doi.org/10.3322/caac.21834.

2. Huang J, et al. Updated epidemiology of gastrointestinal cancers in East Asia. Nat Rev Gastroenterol Hepatol. 2023;20:271–87. https://doi.org/10.1038/s41575-022-00726-3.

3. Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol. 2004;22:329–60. https://doi.org/10.1146/annurev.immunol.22.012703.104803.

4. Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39:1–10. https://doi.org/10.1016/j.immuni.2013.07.012.

5. Janjigian YY, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398:27–40. https://doi.org/10.1016/s0140-6736(21)00797-2.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell RNA sequencing to map tumor heterogeneity in gastric carcinogenesis paving roads to individualized therapy;Cancer Immunology, Immunotherapy;2024-09-13